Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2.787
Zitationen
10
Autoren
2021
Jahr
Abstract
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.
Ähnliche Arbeiten
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
2020 · 51.611 Zit.
Clinical Characteristics of Coronavirus Disease 2019 in China
2020 · 31.072 Zit.
A Novel Coronavirus from Patients with Pneumonia in China, 2019
2020 · 30.214 Zit.
A pneumonia outbreak associated with a new coronavirus of probable bat origin
2020 · 23.213 Zit.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 · 22.630 Zit.